Man Group PLC Cor Medix Inc. Transaction History

Man Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$3.0 - $4.01 $105,000 - $140,350	35,000 New	35,000 $131,000
Q1 2023 May 15, 2023	BUY	$3.22 - $4.61 $71,335 - $102,129	22,154 New	22,154 $91,000
Q3 2021 Nov 15, 2021	SELL	$4.46 - $7.11 $58,426 - $93,141	-13,100 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.05 - $10.09 $79,255 - $132,179	13,100 New	13,100 $90,000

104

17.4M

134K

441K

Ticker CRMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,208,200
Market Cap $426M
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.